Bio Vitos Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Bio Vitos Pharma has a total shareholder equity of SEK32.9M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK33.9M and SEK1.0M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr3.07m |
| Equity | kr32.91m |
| Total liabilities | kr1.01m |
| Total assets | kr33.92m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: BIOVIT's short term assets (SEK5.1M) exceed its short term liabilities (SEK1.0M).
Long Term Liabilities: BIOVIT has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BIOVIT is debt free.
Reducing Debt: BIOVIT has no debt compared to 5 years ago when its debt to equity ratio was 3.4%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BIOVIT has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BIOVIT has less than a year of cash runway if free cash flow continues to grow at historical rates of 7.9% each year.